The historical rank and industry rank for Surmodics's OCF Margin % or its related term are showing as below:
SRDX'
s OCF Margin % Range Over the Past 10 Years
Min: -17.23 Med: 14.71 Max: 41.87
Current: -1.56
During the past 13 years, the highest OCF Margin % of Surmodics was 41.87%. The lowest was -17.23%. And the median was 14.71%.
SRDX's OCF Margin % is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 5.86
vs SRDX: -1.56
Surmodics OCF Margin % Related Terms
Surmodics OCF Margin % Historical Data
* Premium members only.
The historical data trend for Surmodics's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Surmodics's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Surmodics OCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Surmodics's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Surmodics's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Surmodics (SRDX) has a OCF Margin % of 4.75% as of Jun. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Surmodics and its competitors. This is 68% below median its historical median of 14.71.
Is Surmodics' OCF Margin % too high?
Surmodics' current OCF Margin % of 4.75% is 68% below median its 10-year median of 14.71. The Medical Devices & Instruments industry median OCF Margin % is 5.86. Surmodics' value of 4.75% is 18.9% below this industry median. Overall, Surmodics has a GF Score™ of 51/100, reflecting its overall financial health beyond just this single metric.
How does Surmodics' OCF Margin % compare to CBLL and OFIX?
Surmodics' OCF Margin % of 4.75% can be compared against companies in the Medical Devices & Instruments industry. The industry median OCF Margin % is 5.86. Surmodics' value of 4.75% is 18.9% below this benchmark. While the company's 10-year median is 14.71 vs. the industry median of 5.86, Surmodics has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 5.86, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Surmodics's current OCF Margin % of 4.75% is 18.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Surmodics and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 5.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Surmodics's current OCF Margin % is 4.75%, which is 68% below median its own 10-year median of 14.71. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Surmodics stock overvalued right now?
Surmodics (SRDX) has a current OCF Margin % of 4.75%. The stock's GF Value™ is $32.10, compared to a current price of $42.98 — trading 33.9% above its estimated fair value. The current OCF Margin % is 4.75%, which is 68% below median its 10-year median of 14.71 and 18.9% below the Medical Devices & Instruments industry median of 5.86. Surmodics' overall GF Score™ is 51/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Surmodics (SRDX), the current OCF Margin % is 4.75% as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Surmodics (SRDX) Overvalued in 2026?
Based on GuruFocus' analysis, Surmodics stock appears to be overvalued.
The current stock price of $42.98 is trading 33.9% above its estimated GF Value™ of $32.10.
Key valuation signals for SRDX:
OCF Margin %: 4.75% (68% below median its 10-year median of 14.71)
GF Value™: $32.10 vs. price of $42.98 (33.9% above fair value)
Industry Position: 18.9% below the Medical Devices & Instruments median
No single metric tells the full story. See the SRDX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Surmodics Inc is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The company's reportable segments are; Medical Device and In Vitro Diagnostics. Maximum revenue for the company is derived from its Medical Device segment which is involved in the manufacturing and licensing of performance coatings, including surface modification coating technologies and drug-delivery coating technologies. This segment also manufactures vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. Geographically, the company derives key revenue from its domestic market.
51GF Score
Get the complete analysis for SRDX
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SRDX has been successfully added to your 
